fagron semaglutide Oral Demonstrates Greater Weight Loss vs Orforglipron in Indirect Comparison Pharmacotherapy for Weight Loss: Medications

For those considering surgery versus medication, understanding that these pharmaceutical options now approach surgical efficacy may affect decision-making

14.3 Weight Reduction and Long-term Maintenance Study of WEGOVY Injection in Pediatric Patients Aged 12 Years and Older with Obesity Overview of Clinical Trial in Pediatric Patients WEGOVY injection was evaluated to reduce excess body weight in pediatric patients aged 12 years of age and older with obesity in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pubertal pediatric patients aged 12 years and older with BMI corresponding to 95th percentile standardized for age and sex (Study 10) (NCT#04102189)

Preserving lean muscle supports metabolic health and long-term results

The effect of supplementing sheep with rapeseed and linseed oils on the activity of pancreatic digestive enzymes